Clinical Trial Agreement – Phase 3 Czech RepublicClinical Trial Agreement • July 12th, 2018
Contract Type FiledJuly 12th, 2018Clinical Trial Agreement Smlouva o provedení klinického hodnocení This Clinical Trial Agreement (together with Attachment A, the “Agreement”) among AVEO Pharmaceuticals, Inc., a United States Delaware corporation with an office at One Broadway, 14th Floor, Cambridge, MA 02142 USA (“Sponsor” or “AVEO”) represented by PAREXEL International (IRL) Limited, with a registered address at 70 Sir John Rogerson’s Quay, Dublin 2, Ireland, based on Power of Attorney (“PAREXEL”) And Fakultní nemocnice Hradec Králové, with a place of business at Sokolská 581,500 05 Hradec Králové – Nový Hradec Králové, Czech Republic, Iden.number: 00179906Tax Iden.number: CZ00179906,represented prof. MUDr. Roman Prymula, CSc., Ph.D.(“Institution”)and with a place of business at Department of Oncology and Radiotherapy Fakultní nemocnice Hradec Králové, Fakultní nemocnice Hradec Králové, Sokolská 581,500 05 Hradec Králové – Nový Hradec Králové,Czech republic,(“Investigator”)when signed by all parties, is effective as